Table 3. Ampicillin and cefoxitin susceptibility testing (MIC µg ml−1).
Strain | Genotype | AMP* | AMP+S* | AMP+T* | AMP+C* | CEF |
---|---|---|---|---|---|---|
PM3044 | WT M. abscessus | >256 | >256 | 256 | 256 | 32 |
mc2155 | WT M. smegmatis | 256 | 64 | 32 | 16 | nd |
PM3386 | ΔMAB_2875 | 32 | nd | nd | nd | 16 |
PM3389 | ΔMAB_2833 :: aacC41 | >256 | nd | nd | nd | 32 |
PM3395 | ΔMAB_2875 ΔMAB_2833 :: aacC41 |
32 | nd | nd | nd | 32 |
PM3404 | ΔMAB_2875/pMV261 | 8 | nd | nd | nd | nd |
PM3405 | ΔMAB_2875/pMP1205 | >256 | nd | nd | nd | nd |
*Key: AMP, ampicillin; AMP+S, ampicillin with 4 µg ml−1 sulbactam; AMP+T, ampicillin with 4 µg ml−1 tazobactam;, AMP+C, ampicillin with 4 µg ml−1 clavulanic acid; CEF, cefoxitin; nd, not determined.